Emetrol Cherry (WellSpring Pharmaceutical Corporation)


Welcome to the PulseAid listing for the Emetrol Cherry drug offered from WellSpring Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: WellSpring Pharmaceutical Corporation
NON-PROPRIETARY NAME: phosphorated carbohydrate
SUBSTANCE NAME: DEXTROSE; PHOSPHORIC ACID; FRUCTOSE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2009-06-24
END MARKETING DATE: 0000-00-00


Emetrol Cherry HUMAN OTC DRUG Details:

Item DescriptionEmetrol Cherry from WellSpring Pharmaceutical Corporation
LABELER NAME: WellSpring Pharmaceutical Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1.87; 21.5; 1.87(g/5mL; mg/5mL; g/5mL)
START MARKETING DATE: 2009-06-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65197-201_b5abbe96-76fe-4add-b04b-3a0e25ff581b
PRODUCT NDC: 65197-201
APPLICATION NUMBER:

Other DEXTROSE; PHOSPHORIC ACID; FRUCTOSE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
WellSpring Pharmaceutical CorporationEmetrol Cherry